Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 41.59 | 54.72 | 38.60 | 62.69 | 43.36 |
| Operating profit | 4.68 | 7.76 | 6.83 | 10.23 | 10.03 |
| Interest | 0.62 | 0.22 | 0.04 | 0.02 | - |
| Gross profit | 5.34 | 12.62 | 8.31 | 11.44 | 12.02 |
| EPS (Rs) | 3.65 | 9.31 | 6.00 | 8.47 | 8.97 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 1.28 | 5.08 | 1.52 | 1.22 | 1.99 |
| Stock adjustment | - | - | - | - | - |
| Raw material | 32.76 | 42.11 | 27.92 | 49.00 | 31.52 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.51 | 2.29 | 1.59 | 1.29 | 0.88 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 1.63 | 2.56 | 2.26 | 2.17 | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | - | - | - | - | 0.93 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.26 | 0.16 | 0.16 | 0.09 | 0.04 |
| Taxation | 1.34 | 3.14 | 2.15 | 2.88 | 3.01 |
| Net profit / loss | 3.74 | 9.31 | 6.00 | 8.47 | 8.97 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.23 | 10.00 | 10.00 | 10.00 | 10.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.26 | 14.19 | 17.69 | 16.32 | 23.13 |
| GPM (%) | 12.46 | 21.10 | 20.71 | 17.90 | 26.50 |
| NPM (%) | 8.72 | 15.57 | 14.95 | 13.25 | 19.78 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis